期刊
SEMINARS IN HEMATOLOGY
卷 49, 期 1, 页码 35-42出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.seminhematol.2011.10.003
关键词
-
类别
资金
- Region Pays de Loire
- Association pour la Recherche sur le Cancer (ARC)
- Fondation de France
- Fondation contre la Leucemie
- Agence de Biomedecine
- Association Cent pour Sang la Vie
- Association Laurette Fuguain
- IRGHET
- French National Cancer Institute (PHRC, INCa)
Management of high serum ferritin levels after allogeneic hematopoietic stem cell transplantation (allo-HSCT) should, from the diagnostic standpoint, be based on the pathophysiological mechanisms underlying the development of hyperferritinemia. This knowledge is essential for differentiating increased serum ferritin due to iron overload from non-iron overload situations such as inflammation, metabolic syndrome, or hepatitis. Once body iron overload has been proven, especially by quantifying tissue iron excess with the noninvasive magnetic resonance imaging (MRI) method, it is important, considering the damaging effects of chronic iron overload in these patients, to start iron depletive therapy by oral chelation or phlebotomy. At present, more data are needed to assess the long-term deleterious effects of iron excess in the HSCT population, and to define the most appropriate therapeutic strategy for removing iron burden. Also, preventing iron overload prior to HSCT might prove essential for improving patient prognosis through decreasing HSCT-related mortality. Semin Hematol 49:35-42. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据